%0 Journal Article
%T Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway
%A Jinpu Yu
%A Lei Han
%A Pengpeng Liu
%A Weipeng Zhao
%A Wenwen Zhang
%A Yanan Cheng
%A Yehui Shi
%A Yingnan Ye
%A Zhongsheng Tong
%J Archive of "Cancer Biology & Medicine".
%D 2018
%R 10.20892/j.issn.2095-3941.2017.0188
%K Breast cancer
%K everolimus
%K next-generation sequencing
%K liquid biopsy
%K PI3K/AKT/mTOR
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121052/